Published in Advanced Science, the University of Southern Australian study found that such a procedure would make a viable point-of-care diagnostic tool for hospital use. The biosensor was capable of detecting the Staph enzyme in fluid from a human wound and also distinguish between the enzymes in the wound environment.
Other studies, including one published in June that looked at urinary tract infections, have investigated the use of biosensors to detect infections in advance.
More articles on infection control:
The critical role of point-of-care testing during respiratory season
Many superbug deaths in US go uncounted: 4 things to know
Promising new method developed to detect bacterial infections in newborns
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.